Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies.

Trial Profile

Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies.

Completed
Phase of Trial: Phase III

Latest Information Update: 19 Jun 2017

At a glance

  • Drugs Fludarabine (Primary) ; Busulfan; Melphalan
  • Indications Acute lymphoblastic leukaemia; Acute myeloid leukaemia; Aplastic anaemia; Chronic lymphocytic leukaemia; Chronic myeloid leukaemia; Graft-versus-host disease; Haematological malignancies; Hodgkin's disease; Leukaemia; Lymphoma; Multiple myeloma; Myeloid leukaemia; Myeloproliferative disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Jun 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 03 Jan 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top